News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Japan approves Schering-Plough`s brain tumor drug


Posted on: 07/31/2006

Japan approves Schering-Plough's brain tumor drug

Mon Jul 31, 2006 7:44am ET140
[-] Text [+]

 

NEW YORK, July 31 (Reuters) - Drugmaker Schering-Plough Corp.  on Monday said Japanese regulators approved its Temodal treatment for a type of brain tumor known as malignant glioma.

The approval follows a priority review of the new drug application in Japan, which was granted in September 2005 in order to satisfy an unmet medical need in Japanese patients.

Temodal, marketed as Temodar in the U.S., is approved in 77 countries.


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740